XML 62 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2011
Fair Value Disclosures [Abstract]  
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]
The impact of derivative instruments and their location within the Consolidated Statements of Income and Comprehensive Income was as follows:
 
Derivatives not designated as hedging instruments
Location of Gain
Recognized in Income
 
2011
 
2010
 
2009
Commodity swap agreements
Other operating income, net
 
$

 
$

 
$
1,286

 
 
 
 
 
 
 
 
Fair Value, by Balance Sheet Grouping [Table Text Block]
The following table presents the carrying amount and estimated fair values of financial instruments held by the Company at December 31, 2011 and 2010, using market information and what the Company believes to be appropriate valuation methodologies under generally accepted accounting principles:
 
2011
 
2010
Asset (liability)
Carrying
Amount
 
Fair Value
 
Carrying
Amount
 
Fair Value
Cash and cash equivalents
$
78,603

 
$
78,603

 
$
349,463

 
$
349,463

Current maturities of long-term debt
(28,110
)
 
(29,319
)
 
(93,057
)
 
(98,042
)
Long-term debt
(819,229
)
 
(994,851
)
 
(675,103
)
 
(783,080
)
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Assets measured at fair value on a recurring basis are summarized below:
 
Asset
 
Carrying Value at
December 31, 2011
 
Level 2
 
Carrying Value at
December 31, 2010
 
Level 2
Investment in special-purpose entity
 
$
2,690

 
$
2,690

 
$
2,879

 
$
2,879